Griffin Asset Management, Inc. Biomarin Pharmaceutical Inc Transaction History

Griffin Asset Management, Inc.

$827 Million
Q1 2024

A detailed history of Griffin Asset Management, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Griffin Asset Management, Inc. holds 17,438 shares of BMRN stock, worth $1.41 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

17,438

Previous 17,473 0.2%

Holding current value

$1.41 Million

Previous $1.68 Million 9.56%

% of portfolio

0.18%

Previous 0.22%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$83.81 - $99.0 $2,933 - $3,465	-35 Reduced 0.2%	17,438 $1.52 Million
Q4 2023 Jan 19, 2024	BUY	$76.22 - $98.51 $34,527 - $44,625	453 Added 2.66%	17,473 $1.68 Million
Q2 2023 Aug 01, 2023	BUY	$86.68 - $100.3 $188,529 - $218,152	2,175 Added 14.65%	17,020 $1.48 Million
Q1 2023 May 09, 2023	SELL	$87.74 - $117.27 $9,739 - $13,016	-111 Reduced 0.74%	14,845 $1.44 Million
Q4 2022 Jan 20, 2023	BUY	$80.93 - $108.63 $1.21 Million - $1.62 Million	14,956 New	14,956 $0

Q2 2022 Jul 19, 2022	SELL	$71.48 - $86.85 $331,667 - $402,984	-4,640 Closed	0 $0
Q1 2022 Apr 12, 2022	SELL	$74.28 - $92.69 $544,472 - $679,417	-7,330 Reduced 61.24%	4,640 $358,000
Q4 2021 Jan 28, 2022	BUY	$71.72 - $91.47 $38,728 - $49,393	540 Added 4.72%	11,970 $1.06 Million
Q3 2021 Nov 05, 2021	SELL	$74.77 - $85.47 $36,263 - $41,452	-485 Reduced 4.07%	11,430 $883,000
Q2 2021 Jul 28, 2021	SELL	$75.51 - $84.79 $131,009 - $147,110	-1,735 Reduced 12.71%	11,915 $994,000
Q1 2021 May 04, 2021	BUY	$74.73 - $90.69 $176,736 - $214,481	2,365 Added 20.96%	13,650 $1.03 Million
Q4 2020 Jan 27, 2021	BUY	$72.61 - $90.2 $15,248 - $18,942	210 Added 1.9%	11,285 $990,000
Q3 2020 Nov 12, 2020	BUY	$71.87 - $131.03 $21,920 - $39,964	305 Added 2.83%	11,075 $843,000
Q2 2020 Aug 18, 2020	SELL	$79.55 - $124.22 $5,966 - $9,316	-75 Reduced 0.69%	10,770 $1.33 Million
Q1 2020 May 18, 2020	BUY	$71.37 - $96.85 $774,007 - $1.05 Million	10,845 New	10,845 $916,000
Q3 2019 Nov 05, 2019	SELL	$67.4 - $85.11 $15,839 - $20,000	-235 Closed	0 $0
Q2 2019 Aug 19, 2019	BUY	$80.35 - $93.9 $18,882 - $22,066	235 New	235 $20,000

Others Institutions Holding BMRN

# of Institutions

623

Shares Held

181M

Call Options Held

1.73M

Put Options Held

1.73M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $15B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Griffin Asset Management, Inc. with notifications on news.

Account

Griffin Asset Management, Inc. Biomarin Pharmaceutical Inc Transaction History